Vancomycin vs Daptomycin: evidence, status and structure
A side-by-side look at Vancomycin and Daptomycin, using the data on each VALREXA profile. Neither comparison is a recommendation.
Key differences
- Both sit at the same evidence level: Approved use.
- Both have the same U.S. status category: FDA-approved.
| Vancomycin | Daptomycin | |
| Research class | Approved Peptide Medicines | Approved Peptide Medicines |
| Human evidence | Approved use | Approved use |
| U.S. status | FDA-approved (Vancocin and generics) | FDA-approved (Cubicin and generics) |
| 2026 compounding decision | — | — |
| Amino acids | 7-residue glycopeptide core | 13 (cyclic lipopeptide) |
| Molecular weight | ~1,449 Da | ~1,621 Da |
| Formula | C₆₆H₇₅Cl₂N₉O₂₄ | C₇₂H₁₀₁N₁₇O₂₆ |
| Sequence | Glycopeptide (heptapeptide core with sugars) | Cyclic 13-residue lipopeptide |
| Research period | 1958 | 2003 |
| Safety summary | FDA-approved. IV use requires monitoring of kidney function and drug levels; infusion reactions occur. | FDA-approved. Can cause muscle damage, monitored with a weekly blood test. |
How they differ
Both are IV workhorses for resistant Gram-positive bacteria including MRSA, but they kill in different ways. Vancomycin is a glycopeptide that blocks bacterial cell-wall construction; daptomycin is a cyclic lipopeptide that punches holes in the bacterial membrane. Vancomycin requires blood-level monitoring for kidney safety and cannot be used for pneumonia (daptomycin is inactivated by lung surfactant). Vancomycin has decades more data and remains first-line for MRSA bloodstream infections; daptomycin is a common alternative when vancomycin fails or is not tolerated.
What each one is
Vancomycin: The original last-resort Gram-positive antibiotic, a glycopeptide from soil bacteria. Molecular weight, sequence, research history, human evidence and regulatory status.
Daptomycin: A bacteria-killing lipopeptide antibiotic for serious resistant skin and bloodstream infections. Molecular weight, sequence, research history, human evidence and regulatory status.
Educational reference only. Nothing here is medical advice, a treatment recommendation, or dosing or sourcing guidance. Report an error.